{"id":"W1973331825","doi":"10.1158/1538-7445.am2013-2851","title":"Abstract 2851: Development of an alkalizing antibody-enzyme conjugate for NSCLC treatment that is in Phase I clinical testing.","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Immunoconjugate; Tumor microenvironment; Chemistry; In vivo; Antibody; Cancer cell; Extracellular; Cancer research; Conjugate; Cancer; In vitro; Pancreatic cancer; Pharmacology; Monoclonal antibody; Biochemistry; Biology; Immunology; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005540749,0.0005343329,0.0005366898,0.000371681,0.0001824254,0.0004841702,0.0005556242,0.0006875015,0.004613332],"category_scores_gemma":[0.0002496275,0.0002321671,0.0003587198,0.0002199358,0.0001983483,0.0003435216,0.0001860295,0.0007431046,0.001466928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004319277,"about_ca_system_score_gemma":0.0008887703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001312448,"about_ca_topic_score_gemma":0.002201348,"domain_scores_codex":[0.999876,0.0000303242,0.000008051159,0.00002086488,0.00003312646,0.00003155567],"domain_scores_gemma":[0.9998658,0.00001394433,0.00002791671,0.000009905903,0.00002798762,0.00005451698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.007726055,0.008392762,0.003491193,0.001118409,0.0002679242,0.0005065235,0.0001686171,0.003116681,0.7197062,0.001116639,0.008628771,0.2457602],"study_design_scores_gemma":[0.02869583,0.264586,0.04119106,0.0002814978,0.0006995894,0.005306684,0.0001915318,0.01363674,0.5314175,0.0006669529,0.1132111,0.0001154875],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9338671,0.01823698,0.01226116,0.001282355,0.000444748,0.004953925,0.003724526,0.0007069593,0.02452222],"genre_scores_gemma":[0.962592,0.007850675,0.007791345,0.0007938495,0.00007504226,0.001256042,0.005386096,0.00007155811,0.01418339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004613332,"threshold_uncertainty_score":0.01543313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.212339236930653,"score_gpt":0.4933378677471322,"score_spread":0.2809986308164792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}